Market Risers: Ilika, ImmuPharma, International Consolidated Airlines

Ilika Plc

Shares of Ilika with EPIC code: LON:IKA has moved up 4.55% or 1 points during today’s session so far. Market buyers have stayed positive throughout the session. The periods high has reached 23 while the low for the session was 22.4. Volume total for shares traded at this point reached 15,000 with the average number of shares traded daily being 93,453. The stock 52 week high is 40 which comes in at 18 points in difference on the previous days close and a 52 week low being 11.25 a difference of some 10.75 points. Ilika now has a 20 simple moving average of 22.51 and a 50 day moving average now of 22.18. The market capitalisation currently stands at £23.18m at the time of this report. Share price is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Ilika being recorded at Friday, November 1, 2019 at 11:49:13 AM GMT with the stock price trading at 23 GBX.

Shares in ImmuPharma EPIC code: LON:IMM has stepped up 3.63% or 0.31 points during the course of today’s session so far. Market buyers have remained positive while the stock has been in play. The period high was 8.89 and a low of 8.5. Volume total for shares traded at this point reached 88,402 whilst the average number of shares exchanged is 393,285. The 52 week high is 21.81 amounting to 13.26 points in difference on the previous days close and a 52 week low being 8.5 making a difference of 0.050 points. ImmuPharma has a 20 day moving average of 9.84 and now its 50 day moving average now at 10.08. Market capitalisation for the company is £14.83m at the time of this report. The currency for this stock is Great British pence.Market cap is measured in GBP. This article was written with the last trade for ImmuPharma being recorded at Friday, November 1, 2019 at 11:47:02 AM GMT with the stock price trading at 8.86 GBX.

Stock in International Consolidated Airlines with ticker code: LON:IAG has gained 1.36% or 7.2 points in today’s trading session so far. Investors seem confident during this period. The high for the period has reached 538.6 and hitting a low of 530.8. Volume total for shares traded during this period was 2,835,424 with the average number of shares traded daily being 8,301,899. The 52 week high for the share price is 669.41 some 138.21 points in difference on the previous days close and a 52 week low being 411.5 is a variance of 119.7 points. International Consolidated Airlines has a 20 day moving average of 508.03 and a 50 day moving average now of 475.56. The market capitalisation is now £10,683.63m at the time of this report. The stock is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for International Consolidated Airlns Grp SA being recorded at Friday, November 1, 2019 at 12:10:58 PM GMT with the stock price trading at 538.4 GBX.

Share on:
Find more news, interviews, share price & company profile here for:

Ilika FY25 results: Stereax manufacturing shift, Goliath roadmap

Ilika reported results for the year ended 30 April 2025. The group advanced transfer of Stereax miniature solid state battery manufacturing to Cirtec in the US and validated Goliath EV prototypes, including scale up work at UKBIC.

Ilika secures £1.25 million grant for Goliath A-sample production

Ilika will receive £1.25 million from the APC Demonstrate fund to produce its first Goliath A-Sample solid-state batteries in a 12-month PRIMED programme with HSSMI and UKBIC, starting 1 August 2025.

Ilika raises £0.9m in upsized retail offer

Ilika plc announces the conclusion of its oversubscribed Retail Offer, raising £0.9 million and increasing gross proceeds to approximately £4.2 million.

Ilika launches £3.8m fundraise including £0.5m Retail Offer

Ilika Plc has successfully closed its accelerated bookbuild, raising approximately £3.3 million to enhance solid-state battery technology and commercial growth.

Ilika announces £3.5m fundraise via Placing and Retail Offer

Ilika Plc, a leader in solid-state battery technology, plans to raise approximately £3.0 million through a new share placing and a retail offer for shareholders.

Ilika’s Goliath prototypes win OEM validation

Ilika plc has confirmed its P1 Goliath solid-state battery prototypes meet specifications, showcasing significant progress in testing and commercial viability.

Search

Search